Liquidia (NASDAQ:LQDA) Shares Down 6.1% Following Analyst Downgrade
Liquidia Corporation (NASDAQ:LQDA – Get Free Report)’s share price was down 6.1% on Monday after Wells Fargo & Company downgraded the stock from an overweight rating to an equal weight rating. Wells Fargo & Company now has a $30.00 price target on the stock, down from their previous price target of $108.00. Liquidia traded as […]
Forbright (NASDAQ:FRBT) Shares Up 5.6% Following Analyst Upgrade
Forbright, Inc. (NASDAQ:FRBT – Get Free Report)’s share price rose 5.6% on Thursday after JPMorgan Chase & Co. upgraded the stock from a neutral rating to an overweight rating. JPMorgan Chase & Co. now has a $22.00 price target on the stock, down from their previous price target of $23.00. Forbright traded as high as […]
Amazon.com (NASDAQ:AMZN) Shares Climb 1% Following Analyst Upgrade
Shares of Amazon.com, Inc. (NASDAQ:AMZN) rose 1% during trading on Wednesday after Rosenblatt Securities raised their price target on the stock from $335.00 to $360.00. Rosenblatt Securities currently has a buy rating on the stock. Amazon.com traded as high as $252.44 and last traded at $249.15. 41,246,155 shares were traded during trading, a decline of […]
Grocery Outlet (NASDAQ:GO) Shares Gap Up Following Analyst Upgrade
Grocery Outlet Holding Corp. (NASDAQ:GO – Get Free Report)’s share price gapped up prior to trading on Wednesday after Bank of America upgraded the stock from a neutral rating to a buy rating. The stock had previously closed at $10.95, but opened at $11.64. Bank of America now has a $15.00 price target on the […]
Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.4% on Analyst Downgrade
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) were down 5.4% during mid-day trading on Tuesday after Deutsche Bank Aktiengesellschaft lowered their price target on the stock from $280.00 to $267.00. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock. Axsome Therapeutics traded as low as $183.35 and last traded at […]
Tesla (NASDAQ:TSLA) Shares Down 1.5% Following Analyst Downgrade
Tesla, Inc. (NASDAQ:TSLA – Get Free Report)’s share price fell 1.5% on Friday after BNP Paribas Exane lowered their price target on the stock from $280.00 to $268.00. BNP Paribas Exane currently has an underperform rating on the stock. Tesla traded as low as $367.67 and last traded at $372.11. 44,520,130 shares traded hands during […]
last updated on 6 Oct 07:12